We found that serum levels of GPC1 can distinguish between PDAC and gallbladder carcinoma, colorectal carcinoma, gastric carcinoma, and prostate cancer, but could not differentiate PDAC from hepatocellular carcinoma and cholangiocarcinoma. Here, GPC1 is linked to gastric carcinoma.